Cargando…
The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
BACKGROUND: The aim of this study was to determine the efficacy and safety of acupuncture treatment (AT) or acupuncture plus conventional medicine (CM) versus CM alone using a meta-analysis of all published randomized controlled trials (RCTs) for nonalcoholic fatty liver disease (NAFLD). METHODS: Ei...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462626/ https://www.ncbi.nlm.nih.gov/pubmed/34559098 http://dx.doi.org/10.1097/MD.0000000000027050 |
_version_ | 1784572237824655360 |
---|---|
author | Chen, Peiwen Zhong, Xin Dai, Yunkai Tan, Meiao Zhang, Gaochuan Ke, Xuehong Huang, Keer Zhou, Zunming |
author_facet | Chen, Peiwen Zhong, Xin Dai, Yunkai Tan, Meiao Zhang, Gaochuan Ke, Xuehong Huang, Keer Zhou, Zunming |
author_sort | Chen, Peiwen |
collection | PubMed |
description | BACKGROUND: The aim of this study was to determine the efficacy and safety of acupuncture treatment (AT) or acupuncture plus conventional medicine (CM) versus CM alone using a meta-analysis of all published randomized controlled trials (RCTs) for nonalcoholic fatty liver disease (NAFLD). METHODS: Eight databases were searched independently from inception to April 30, 2020. RCTs were included if they contained reports on the use acupuncture or the use of acupuncture combined with CM and compared with the use of CM. Summary odds ratio (OR) and 95% confidence intervals (CIs) were used to calculate the overall clinical efficacy. Secondary outcomes, namely aspartate aminotransferase, alanine aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and body mass index, were calculated by mean difference with 95% CIs. RESULTS: After the final screening, 8 RCTs with 939 patients were included. This meta-analysis showed that AT was superior to CM in improving overall clinical efficacy (OR = 3.19, 95% CI: 2.06–4.92, P < .00001). In addition, AT plus CM could significantly improve overall clinical efficacy compared to treatment with CM alone (OR = 5.11, 95% CI: 2.43–10.75, P < .0001). Moreover, the benefits were also demonstrated in other outcomes, including alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol indexes. However, AT plus CM could not decrease body mass index levels in comparison with CM. The safety profile of Acupuncture therapy was satisfactory. Taichong, Zusanli, Fenglong, and Sanyinjiao were major acupoints on NAFLD treatment. CONCLUSION: Acupuncture may be effective and safe for treatment of NAFLD. However, due to insufficient methodological quality and sample size, further high-quality studies are needed. |
format | Online Article Text |
id | pubmed-8462626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-84626262021-09-27 The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials Chen, Peiwen Zhong, Xin Dai, Yunkai Tan, Meiao Zhang, Gaochuan Ke, Xuehong Huang, Keer Zhou, Zunming Medicine (Baltimore) 3800 BACKGROUND: The aim of this study was to determine the efficacy and safety of acupuncture treatment (AT) or acupuncture plus conventional medicine (CM) versus CM alone using a meta-analysis of all published randomized controlled trials (RCTs) for nonalcoholic fatty liver disease (NAFLD). METHODS: Eight databases were searched independently from inception to April 30, 2020. RCTs were included if they contained reports on the use acupuncture or the use of acupuncture combined with CM and compared with the use of CM. Summary odds ratio (OR) and 95% confidence intervals (CIs) were used to calculate the overall clinical efficacy. Secondary outcomes, namely aspartate aminotransferase, alanine aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and body mass index, were calculated by mean difference with 95% CIs. RESULTS: After the final screening, 8 RCTs with 939 patients were included. This meta-analysis showed that AT was superior to CM in improving overall clinical efficacy (OR = 3.19, 95% CI: 2.06–4.92, P < .00001). In addition, AT plus CM could significantly improve overall clinical efficacy compared to treatment with CM alone (OR = 5.11, 95% CI: 2.43–10.75, P < .0001). Moreover, the benefits were also demonstrated in other outcomes, including alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol indexes. However, AT plus CM could not decrease body mass index levels in comparison with CM. The safety profile of Acupuncture therapy was satisfactory. Taichong, Zusanli, Fenglong, and Sanyinjiao were major acupoints on NAFLD treatment. CONCLUSION: Acupuncture may be effective and safe for treatment of NAFLD. However, due to insufficient methodological quality and sample size, further high-quality studies are needed. Lippincott Williams & Wilkins 2021-09-24 /pmc/articles/PMC8462626/ /pubmed/34559098 http://dx.doi.org/10.1097/MD.0000000000027050 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | 3800 Chen, Peiwen Zhong, Xin Dai, Yunkai Tan, Meiao Zhang, Gaochuan Ke, Xuehong Huang, Keer Zhou, Zunming The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials |
title | The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials |
title_full | The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials |
title_fullStr | The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials |
title_full_unstemmed | The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials |
title_short | The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials |
title_sort | efficacy and safety of acupuncture in nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462626/ https://www.ncbi.nlm.nih.gov/pubmed/34559098 http://dx.doi.org/10.1097/MD.0000000000027050 |
work_keys_str_mv | AT chenpeiwen theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhongxin theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT daiyunkai theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT tanmeiao theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhanggaochuan theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT kexuehong theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT huangkeer theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhouzunming theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT chenpeiwen efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhongxin efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT daiyunkai efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT tanmeiao efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhanggaochuan efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT kexuehong efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT huangkeer efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT zhouzunming efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials |